Australian Technical Advisory Group on Immunisation gives the final approval for use of the Novavax COVID-19 vaccine for people over the age of 18 years.
The Australian Technical Advisory Group on Immunisation gives the final approval for use of the Novavax COVID-19 vaccine for people over the age of 18 years. The rollout of the vaccine will begin on February 21.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthAustralian Technical Advisory Group on Immunisation gives the final approval for use of the Novavax COVID-19 vaccine for people over the age of 18 years.
View Premium plansBrowse free archive reportsThe Australian Technical Advisory Group on Immunisation gives the final approval for use of the Novavax COVID-19 vaccine for people over the age of 18 years. The rollout of the vaccine will begin on February 21.